Prograf (Astellas Pharma US, Inc.)
Welcome to the PulseAid listing for the Prograf drug offered from Astellas Pharma US, Inc.. This Calcineurin Inhibitor Immunosuppressant [EPC],Calcineurin Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Astellas Pharma US, Inc. |
NON-PROPRIETARY NAME: | Tacrolimus |
SUBSTANCE NAME: | TACROLIMUS |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Calcineurin Inhibitor Immunosuppressant [EPC],Calcineurin Inhibitors [MoA] |
ROUTE: | INTRAVENOUS |
DOSAGE FORM: | INJECTION, SOLUTION |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 1994-04-08 |
END MARKETING DATE: | 0000-00-00 |
Prograf HUMAN PRESCRIPTION DRUG Details:
Item Description | Prograf from Astellas Pharma US, Inc. |
LABELER NAME: | Astellas Pharma US, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 5(mg/mL) |
START MARKETING DATE: | 1994-04-08 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0469-3016_426e5fca-bc45-400f-9d6e-355559f7554e |
PRODUCT NDC: | 0469-3016 |
APPLICATION NUMBER: | NDA050709 |
Other TACROLIMUS Pharmaceutical Manufacturers / Labelers: